journal article·2023

Magnetic enrichment of immuno-specific extracellular vesicles for mass spectrometry using biofilm-derived iron oxide nanowires

Quang Nghia Pham, Marnie Winter, Valentina Milanova, Clifford Young, Mark R. Condina, Peter Hoffmann, Nguyen T. H. Pham, Tran Thanh Tung, Dusan Losic, Benjamin Thierry

Nanoscale· Volume 15· Issue 3
Publisher page

Abstract

Immuno-specific enrichment of extracellular vesicles (EVs) can provide important information into cellular pathways underpinning various pathologies and for non-invasive diagnostics, including mass spectrometry-based analyses. Herein, we report an optimised protocol for immuno-magnetic enrichment of specific EV subtypes and their subsequent processing with liquid chromatography-tandem mass spectrometry (LC-MS/MS). Specifically, we conjugated placental alkaline phosphatase (PLAP) antibodies to magnetic iron oxide nanowires (NWs) derived from bacterial biofilms and demonstrated the utility of this approach by enriching placenta-specific EVs (containing PLAP) from cell culture media. We demonstrate efficient PLAP+ve EV enrichment for both NW-PLAP and Dynabeads™-PLAP, with high PLAP protein recovery (83.7 ± 8.9% and 83.2 ± 5.9%, respectively), high particle-to-protein ratio (7.5 ± 0.7 × 109 and 7.1 ± 1.2 × 109, respectively), and low non-specific binding of non-target EVs (7 ± 3.2% and 5.4 ± 2.2%, respectively). Furthermore, our optimized EV enrichment and processing approach identified 2518 and 2545 protein groups with LC-MS/MS for NW-PLAP and Dynabead™-PLAP, respectively, with excellent reproducibility (Pearson correlation 0.986 and 0.988). These findings demonstrate that naturally occurring iron oxide NWs have comparable performance to current gold standard immune-magnetic beads. The optimized immuno-specific EV enrichment for LC-MS/MS method provides a low-cost and highly-scalable yet efficient, high-throughput approach for quality EV proteomic studies.
Source: europepmc · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Extracellular vesicles in disease · Characterization and Applications of Magnetic Nanoparticles · Nanopore and Nanochannel Transport Studies

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Future Industries Institute, University of South Australia, Mawson Lakes Campus, Mawson Lakes, Adelaide, South Australia 5095, Australia

Clinical and Health Sciences, University of South Australia, City West Campus, Adelaide, South Australia 5000, Australia

School of Chemistry, The University of Sydney, Sydney, New South Wales 2006, Australia

School of Chemical Engineering and Advanced Materials, The University of Adelaide, Adelaide, South Australia 5005, Australia

Funding

Thrasher Research Fund · National Health and Medical Research Council · Australian Research Council

References (63)

Show source-provided references
1. Shao · Chem. Rev. · 2018 · 118 · 191710.1021/acs.chemrev.7b00534 ↗
2. Sun · Anal. Chim. Acta · 2017 · 982 · 8410.1016/j.aca.2017.06.005 ↗
3. Yuana · Blood Rev. · 2013 · 27 · 3110.1016/j.blre.2012.12.002 ↗
4. Maas · Trends Cell Biol. · 2017 · 27 · 17210.1016/j.tcb.2016.11.003 ↗
5. Raposo · Nat. Rev. Mol. Cell Biol. · 2019 · 20 · 50910.1038/s41580-019-0158-7 ↗
6. Kadota · Eur. Respir. Rev. · 2022 · 31 · 21010610.1183/16000617.0106-2021 ↗
7. O'Brien · Nat. Rev. Mol. Cell Biol. · 2020 · 21 · 58510.1038/s41580-020-0251-y ↗
8. Karasu · Front. Immunol. · 2018 · 9 · 72110.3389/fimmu.2018.00721 ↗
9. Chen · Proc. Natl. Acad. Sci. U. S. A. · 2017 · 114 · 317510.1073/pnas.1618088114 ↗
10. Heydari · Expert Rev. Mol. Diagn. · 2021 · 21 · 93910.1080/14737159.2021.1954909 ↗
11. Tian · Nat. Commun. · 2021 · 12 · 253610.1038/s41467-021-22913-7 ↗
12. Dickhout · Front. Cardiovasc. Med. · 2018 · 5 · 11310.3389/fcvm.2018.00113 ↗
13. Margolis · PLos Biol. · 2019 · 17 · e300036310.1371/journal.pbio.3000363 ↗
14. Melo · Nature · 2015 · 523 · 17710.1038/nature14581 ↗
15. Thery · J. Extracell. Vesicles · 2018 · 7 · 153575010.1080/20013078.2018.1535750 ↗
16. Brennan · Sci. Rep. · 2020 · 10 · 103910.1038/s41598-020-57497-7 ↗
17. Murphy · Exp. Mol. Med. · 2019 · 51 · 110.1038/s12276-019-0223-5 ↗
18. Marcoux · Sci. Rep. · 2016 · 6 · 3592810.1038/srep35928 ↗
19. Liangsupree · J. Chromatogr. A · 2021 · 1636 · 46177310.1016/j.chroma.2020.461773 ↗
20. Singh · Analyst · 2021 · 146 · 373110.1039/D1AN00024A ↗
21. Rosi · Chem. Rev. · 2005 · 105 · 154710.1021/cr030067f ↗
22. Gudbergsson · Cytotechnology · 2016 · 68 · 57910.1007/s10616-015-9913-6 ↗
23. Yang · Theranostics · 2020 · 10 · 368410.7150/thno.41580 ↗
24. Contreras-Naranjo · Lab Chip · 2017 · 17 · 355810.1039/C7LC00592J ↗
25. Cai · Nanoscale · 2018 · 10 · 1428010.1039/C8NR02871K ↗
26. Reategui · Nat. Commun. · 2018 · 9 · 17510.1038/s41467-017-02261-1 ↗
27. Rosa-Fernandes · Front. Chem. · 2017 · 5 · 10210.3389/fchem.2017.00102 ↗
28. Hildonen · Sci. Rep. · 2016 · 6 · 3633110.1038/srep36331 ↗
29. Farhana · ACS Appl. Nano Mater. · 2021 · 4 · 117510.1021/acsanm.0c02807 ↗
30. Pedersen · Methods Mol. Biol. · 2017 · 1660 · 6510.1007/978-1-4939-7253-1_7 ↗
31. Takahashi · Chem. Commun. · 2021 · 57 · 1323410.1039/D1CC05096F ↗
32. Hong · Biomaterials · 2016 · 106 · 7810.1016/j.biomaterials.2016.08.020 ↗
33. Nemati · ACS Appl. Nano Mater. · 2020 · 3 · 205810.1021/acsanm.0c00263 ↗
34. Nemati · Nanomaterials · 2020 · 10 · 166210.3390/nano10091662 ↗
35. Lim · J. Nanobiotechnol. · 2019 · 17 · 110.1186/s12951-018-0433-3 ↗
36. Lee · Theranostics · 2018 · 8 · 50510.7150/thno.21967 ↗
37. Kumeria · Biomacromolecules · 2016 · 17 · 272610.1021/acs.biomac.6b00786 ↗
38. Sarker · J. Transl. Med. · 2014 · 12 · 20410.1186/1479-5876-12-204 ↗
39. Chaparro · Diagnostics · 2021 · 11 · 66110.3390/diagnostics11040661 ↗
40. Jin · Am. J. Reprod. Immunol. · 2018 · 79 · e1278810.1111/aji.12788 ↗
41. Sadovsky · Placenta · 2020 · 102 · 3410.1016/j.placenta.2020.03.002 ↗
42. Wang · ACS Appl. Mater. Interfaces · 2016 · 8 · 2011010.1021/acsami.6b06486 ↗
43. Bryce · Biomater. Sci. · 2013 · 1 · 126010.1039/C3BM60120J ↗
44. Thierry · J. Mater. Chem. · 2012 · 22 · 881010.1039/c2jm30210a ↗
45. Théry · Curr. Protoc. Cell Biol. · 2006 · 30 · 310.1002/0471143030.cb0322s30 ↗
46. Fischer · Proteomics · 2015 · 15 · 122410.1002/pmic.201400436 ↗
47. Cox · Nat. Biotechnol. · 2008 · 26 · 136710.1038/nbt.1511 ↗
48. Huang da · Nat. Protoc. · 2009 · 4 · 4410.1038/nprot.2008.211 ↗
49. Liu · Macromol. Chem. Phys. · 2012 · 213 · 169710.1002/macp.201200154 ↗
50. Flak · Appl. Surf. Sci. · 2018 · 455 · 101910.1016/j.apsusc.2018.06.002 ↗
51. Alduhaish · Sci. Rep. · 2019 · 9 · 1413910.1038/s41598-019-50780-2 ↗
52. Levine · Sci. Rep. · 2020 · 10 · 639810.1038/s41598-020-62193-7 ↗
53. Webber · J. Extracell. Vesicles · 2013 · 2 · 1986110.3402/jev.v2i0.19861 ↗
54. Bellotti · Sci. Rep. · 2021 · 11 · 1055010.1038/s41598-021-90022-y ↗
55. Chen · PLoS One · 2020 · 15 · e022961010.1371/journal.pone.0229610 ↗
56. Menon · Endocrinology · 2020 · 161 · 110.1210/endocr/bqaa009 ↗
57. Boriachek · Anal. Chem. · 2019 · 91 · 382710.1021/acs.analchem.8b03619 ↗
58. Sodar · Expert Rev. Proteomics · 2017 · 14 · 107310.1080/14789450.2017.1392244 ↗
59. Tauro · Methods · 2012 · 56 · 29310.1016/j.ymeth.2012.01.002 ↗
60. Weng · Analyst · 2016 · 141 · 464010.1039/C6AN00892E ↗
61. Gill · Hypertension · 2019 · 73 · 111210.1161/HYPERTENSIONAHA.119.12707 ↗
62. Dragovic · Methods · 2015 · 87 · 6410.1016/j.ymeth.2015.03.028 ↗
63. Lv · J. Cell. Mol. Med. · 2019 · 23 · 789410.1111/jcmm.14667 ↗